Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in Am J Psychiatry

Retrieve available abstracts of 192 articles:
HTML format

Single Articles

    July 2021
  1. ROXAS N, Ahuja C, Isom J, Wilkinson ST, et al
    A Potential Case of Acute Ketamine Withdrawal: Clinical Implications for the Treatment of Refractory Depression.
    Am J Psychiatry. 2021;178:588-591.

    June 2021
    Using the Power of a Giant Wisely: Confirming Inflammation in Depression.
    Am J Psychiatry. 2021;178:480-482.

    COVID-19 and Stress-Related Disorders.
    Am J Psychiatry. 2021;178:471-474.

  4. RUBINOW DR, Lasser R, Kanes SJ
    Comment on "Understanding the Clinical Effects and Mechanisms of Action of Neurosteroids".
    Am J Psychiatry. 2021;178:572-573.

    May 2021
  5. PITHAROULI MC, Hagenaars SP, Glanville KP, Coleman JRI, et al
    Elevated C-Reactive Protein in Patients With Depression, Independent of Genetic, Health, and Psychosocial Factors: Results From the UK Biobank.
    Am J Psychiatry. 2021 May 14:appiajp202020060947.
    PubMed     Abstract available

  6. MAIXNER DF, Weiner R, Reti IM, Hermida AP, et al
    Electroconvulsive Therapy Is an Essential Procedure.
    Am J Psychiatry. 2021;178:381-382.

    Can Target Engagement Studies Miss Their Targets and Mislead Drug Development?
    Am J Psychiatry. 2021;178:372-374.

    April 2021
    Anxiety, Depression, and Suicide in Youth.
    Am J Psychiatry. 2021;178:275-279.

  9. PARIKH T, Walkup JT
    The Future of Ketamine in the Treatment of Teen Depression.
    Am J Psychiatry. 2021;178:288-289.

    The Trifecta of Misery and Disease Vulnerability: Poverty, Childhood Maltreatment, and Inflammation.
    Am J Psychiatry. 2021;178:282-284.

  11. BOELEN PA, Lenferink LIM, Spuij M
    CBT for Prolonged Grief in Children and Adolescents: A Randomized Clinical Trial.
    Am J Psychiatry. 2021;178:294-304.
    PubMed     Abstract available

  12. SEQUEIRA SL, Silk JS, Ladouceur CD, Hanson JL, et al
    Association of Neural Reward Circuitry Function With Response to Psychotherapy in Youths With Anxiety Disorders.
    Am J Psychiatry. 2021;178:343-351.
    PubMed     Abstract available

  13. BIERMAN KL, Heinrichs BS, Welsh JA, Nix RL, et al
    Reducing Adolescent Psychopathology in Socioeconomically Disadvantaged Children With a Preschool Intervention: A Randomized Controlled Trial.
    Am J Psychiatry. 2021;178:305-312.
    PubMed     Abstract available

    March 2021
  14. MCINTYRE RS, Rosenblat JD, Nemeroff CB, Sanacora G, et al
    Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation.
    Am J Psychiatry. 2021 Mar 17:appiajp202020081251.
    PubMed     Abstract available

  15. DWYER JB, Landeros-Weisenberger A, Johnson JA, Londono Tobon A, et al
    Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial.
    Am J Psychiatry. 2021 Mar 3:appiajp202020010018.
    PubMed     Abstract available

  16. COSTI S, Morris LS, Kirkwood KA, Hoch M, et al
    Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial.
    Am J Psychiatry. 2021 Mar 3:appiajp202020050653.
    PubMed     Abstract available

    One Small Step for PMDD, One Large Step for Affective Disorders.
    Am J Psychiatry. 2021;178:215-217.

  18. COMASCO E, Kopp Kallner H, Bixo M, Hirschberg AL, et al
    Ulipristal Acetate for Treatment of Premenstrual Dysphoric Disorder: A Proof-of-Concept Randomized Controlled Trial.
    Am J Psychiatry. 2021;178:256-265.
    PubMed     Abstract available

  19. KLEINMAN RA, Schatzberg AF
    Understanding the Clinical Effects and Mechanisms of Action of Neurosteroids.
    Am J Psychiatry. 2021;178:221-223.

    February 2021
  20. SUMMERS RF, Gorrindo T, Hwang S, Aggarwal R, et al
    Psychiatrist Burnout: Response to Schonfeld and Bianchi.
    Am J Psychiatry. 2021;178:204-205.

  21. SCHONFELD IS, Bianchi R
    Psychiatrist Burnout.
    Am J Psychiatry. 2021;178:204.

  22. FEDER A, Costi S, Rutter SB, Collins AB, et al
    A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder.
    Am J Psychiatry. 2021;178:193-202.
    PubMed     Abstract available

    October 2020
  23. COUGHLIN LN, Pfeiffer P, Ganoczy D, Lin LA, et al
    Quality of Outpatient Depression Treatment in Patients With Comorbid Substance Use Disorder.
    Am J Psychiatry. 2020 Oct 29:appiajp202020040454.
    PubMed     Abstract available

    Is Testosterone an Effective Hormonal Therapy for Women With Antidepressant-Resistant Major Depression?
    Am J Psychiatry. 2020;177:891-894.

  25. KALIN NH
    Insights Into Suicide and Depression.
    Am J Psychiatry. 2020;177:877-880.

    Using Genetics to Increase Specificity of Outcome Prediction in Psychiatric Disorders: Prospects for Progression.
    Am J Psychiatry. 2020;177:884-887.

  27. FIRTH J, Wootton RE, Carvalho AF
    Toward Preventive Psychiatry: The Role of Advanced Epidemiological Methods.
    Am J Psychiatry. 2020;177:888-890.

    The Elephant in the Room: What Burnout Is and What It Is Not.
    Am J Psychiatry. 2020;177:898-899.

  29. MEDINA-RODRIGUEZ EM, Madorma D, O'Connor G, Mason BL, et al
    Identification of a Signaling Mechanism by Which the Microbiome Regulates Th17 Cell-Mediated Depressive-Like Behaviors in Mice.
    Am J Psychiatry. 2020;177:974-990.
    PubMed     Abstract available

  30. DICHTEL LE, Carpenter LL, Nyer M, Mischoulon D, et al
    Low-Dose Testosterone Augmentation for Antidepressant-Resistant Major Depressive Disorder in Women: An 8-Week Randomized Placebo-Controlled Study.
    Am J Psychiatry. 2020;177:965-973.
    PubMed     Abstract available

    August 2020
  31. CHOI KW, Stein MB, Nishimi KM, Ge T, et al
    An Exposure-Wide and Mendelian Randomization Approach to Identifying Modifiable Factors for the Prevention of Depression.
    Am J Psychiatry. 2020 Aug 14:appiajp202019111158.
    PubMed     Abstract available

    The State of Our Understanding of the Pathophysiology and Optimal Treatment of Depression: Glass Half Full or Half Empty?
    Am J Psychiatry. 2020;177:671-685.
    PubMed     Abstract available

    Chasing the Holy Grail: Developmentally Informed Research on Frontostriatal Reward Circuitry in Depression.
    Am J Psychiatry. 2020;177:660-662.

    Mental Health Treatment Utilization in Transgender Persons: What We Know and What We Don't Know.
    Am J Psychiatry. 2020;177:657-659.

  35. CARPENTER LL, Philip NS
    The Future Is Now? Rapid Advances by Brain Stimulation Innovation.
    Am J Psychiatry. 2020;177:654-656.

  36. THASE ME
    Charting Sea Changes in Outpatient Pharmacotherapy of Bipolar Disorder.
    Am J Psychiatry. 2020;177:651-653.

  37. DWYER JB, Aftab A, Radhakrishnan R, Widge A, et al
    Hormonal Treatments for Major Depressive Disorder: State of the Art.
    Am J Psychiatry. 2020;177:686-705.
    PubMed     Abstract available

    July 2020
  38. SUMMERS RF, Gorrindo T, Hwang S, Aggarwal R, et al
    Well-Being, Burnout, and Depression Among North American Psychiatrists: The State of Our Profession.
    Am J Psychiatry. 2020 Jul 14:appiajp202019090901.
    PubMed     Abstract available

  39. MUSLINER KL, Krebs MD, Albinana C, Vilhjalmsson B, et al
    Polygenic Risk and Progression to Bipolar or Psychotic Disorders Among Individuals Diagnosed With Unipolar Depression in Early Life.
    Am J Psychiatry. 2020 Jul 14:appiajp202019111195.
    PubMed     Abstract available

  40. BOYER J
    COVID-19, Medication-Assisted Treatment, and Increased Risk for Further Respiratory Depression.
    Am J Psychiatry. 2020;177:636.

  41. LIN K, Yang BX, Luo D, Liu Q, et al
    The Mental Health Effects of COVID-19 on Health Care Providers in China.
    Am J Psychiatry. 2020;177:635-636.

    June 2020
  42. MALONEY SE, Rogers CE, Constantino JN
    Antidepressants, Pregnancy, and Autism: Setting the Record(s) Straight.
    Am J Psychiatry. 2020;177:479-481.

  43. VEGA ML, Newport GC, Bozhdaraj D, Saltz SB, et al
    Implementation of Advanced Methods for Reproductive Pharmacovigilance in Autism: A Meta-Analysis of the Effects of Prenatal Antidepressant Exposure.
    Am J Psychiatry. 2020;177:506-517.
    PubMed     Abstract available

  44. OSLER M, Jorgensen MB
    Associations of Benzodiazepines, Z-Drugs, and Other Anxiolytics With Subsequent Dementia in Patients With Affective Disorders: A Nationwide Cohort and Nested Case-Control Study.
    Am J Psychiatry. 2020;177:497-505.
    PubMed     Abstract available

    May 2020
  45. KALIN NH
    The Critical Relationship Between Anxiety and Depression.
    Am J Psychiatry. 2020;177:365-367.

  46. WASIL AR, Gillespie S, Shingleton R, Wilks CR, et al
    Examining the Reach of Smartphone Apps for Depression and Anxiety.
    Am J Psychiatry. 2020;177:464-465.

  47. SPELLMAN T, Liston C
    Toward Circuit Mechanisms of Pathophysiology in Depression.
    Am J Psychiatry. 2020;177:381-390.
    PubMed     Abstract available

  48. NESTOR SM, Blumberger DM
    Mapping Symptom Clusters to Circuits: Toward Personalizing TMS Targets to Improve Treatment Outcomes in Depression.
    Am J Psychiatry. 2020;177:373-375.

  49. KENDLER KS, Ohlsson H, Sundquist J, Sundquist K, et al
    The Rearing Environment and Risk for Major Depression: A Swedish National High-Risk Home-Reared and Adopted-Away Co-Sibling Control Study.
    Am J Psychiatry. 2020;177:447-453.
    PubMed     Abstract available

    Is Depression Nature or Nurture? Yes.
    Am J Psychiatry. 2020;177:376-377.

  51. PHILIP NS, Barredo J, Aiken E, Larson V, et al
    Informing Further Research in the Use of Brain Stimulation in Psychiatric Disorders: Response to Syed and Smith.
    Am J Psychiatry. 2020;177:466-467.

  52. SIDDIQI SH, Taylor SF, Cooke D, Pascual-Leone A, et al
    Distinct Symptom-Specific Treatment Targets for Circuit-Based Neuromodulation.
    Am J Psychiatry. 2020;177:435-446.
    PubMed     Abstract available

  53. GRAY JP, Muller VI, Eickhoff SB, Fox PT, et al
    Multimodal Abnormalities of Brain Structure and Function in Major Depressive Disorder: A Meta-Analysis of Neuroimaging Studies.
    Am J Psychiatry. 2020;177:422-434.
    PubMed     Abstract available

    April 2020
  54. GU X, Guo T, Si Y, Wang J, et al
    Association Between Ambient Air Pollution and Daily Hospital Admissions for Depression in 75 Chinese Cities.
    Am J Psychiatry. 2020 Apr 21:appiajp202019070748.
    PubMed     Abstract available

  55. RAPPAPORT BI, Kandala S, Luby JL, Barch DM, et al
    Brain Reward System Dysfunction in Adolescence: Current, Cumulative, and Developmental Periods of Depression.
    Am J Psychiatry. 2020 Apr 7:appiajp201919030281.
    PubMed     Abstract available

  56. COLE EJ, Stimpson KH, Bentzley BS, Gulser M, et al
    Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression.
    Am J Psychiatry. 2020 Apr 7:appiajp201919070720.
    PubMed     Abstract available

    February 2020
  57. KALIN NH
    Treating Substance Use Disorders, Binge Eating, and Depression, and Identifying Factors Underlying Psychosis Risk.
    Am J Psychiatry. 2020;177:101-103.

  58. HUNTER AM, Leuchter AF
    Benzodiazepine Use and rTMS Outcome.
    Am J Psychiatry. 2020;177:172.

  59. KASTER TS, Downar J, Vila-Rodriguez F, Daskalakis ZJ, et al
    Caution When Continuing Benzodiazepines During rTMS: Response to Hunter and Leuchter.
    Am J Psychiatry. 2020;177:172-173.

  60. MATHEW SJ, Price RB
    Ketamine Plus Motivational Enhancement Therapy: Leveraging a Rapid Effect to Promote Enduring Change.
    Am J Psychiatry. 2020;177:107-109.

  61. CUSIN C, Sakurai H, Bentley K, Pedrelli P, et al
    All Suicidal Ideation Is Not Created Equal: Two Cases of Suicide Attempts During Maintenance Ketamine Treatment.
    Am J Psychiatry. 2020;177:173-174.

    December 2019
  62. SCHEELE D, Zimbal S, Feinstein JS, Delis A, et al
    Treatment-Resistant Depression and Ketamine Response in a Patient With Bilateral Amygdala Damage.
    Am J Psychiatry. 2019;176:982-986.

    November 2019
  63. MCSHANE R, Baldwin DS, McAllister-Williams RH, Stone JM, et al
    Esketamine and the Need for a New Type of Registry for Drugs With Abuse Potential.
    Am J Psychiatry. 2019;176:966.

    October 2019
  64. CROWELL AL, Riva-Posse P, Holtzheimer PE, Garlow SJ, et al
    Long-Term Outcomes of Subcallosal Cingulate Deep Brain Stimulation for Treatment-Resistant Depression.
    Am J Psychiatry. 2019 Oct 4:appiajp201918121427.
    PubMed     Abstract available

    More Thoughts on Intranasal Esketamine: Response to Drevets et al.
    Am J Psychiatry. 2019;176:858-859.

  66. DREVETS WC, Singh JB, Hough D, Daly EJ, et al
    Comment on a Word to the Wise About Intranasal Esketamine.
    Am J Psychiatry. 2019;176:856-857.

    September 2019
  67. CHIN FATT CR, Jha MK, Cooper CM, Fonzo G, et al
    Effect of Intrinsic Patterns of Functional Brain Connectivity in Moderating Antidepressant Treatment Response in Major Depression.
    Am J Psychiatry. 2019 Sep 20:appiajp201918070870.
    PubMed     Abstract available

  68. CHOO EK, Girgis C, Han CS, Simard JF, et al
    High Prevalence of Peripartum Depression Among Physician Mothers: A Cross-Sectional Study.
    Am J Psychiatry. 2019;176:763-764.

  69. BARCH DM, Rogers C
    Maternal Depression and Child Development: Clues to Causal Mechanisms From Potential Confounders.
    Am J Psychiatry. 2019;176:680-682.

  70. BECKER MA, Chandy A, Mayer JLW, Sachdeva J, et al
    Psychiatric Aspects of Infertility.
    Am J Psychiatry. 2019;176:765-766.

  71. ZOU R, Tiemeier H, van der Ende J, Verhulst FC, et al
    Exposure to Maternal Depressive Symptoms in Fetal Life or Childhood and Offspring Brain Development: A Population-Based Imaging Study.
    Am J Psychiatry. 2019;176:702-710.
    PubMed     Abstract available

    August 2019
    Predicting Depression.
    Am J Psychiatry. 2019;176:598-599.

  73. LOPES FL, McMahon FJ
    The Promise and Limits of Suicide Genetics.
    Am J Psychiatry. 2019;176:600-602.

  74. BORDER R, Johnson EC, Evans LM, Keller MC, et al
    Measurement Error Cannot Account for Failed Replications of Historic Candidate Gene-by-Environment Hypotheses: Response to Vrshek-Schallhorn et al.
    Am J Psychiatry. 2019;176:668-669.

  75. VRSHEK-SCHALLHORN S, Corneau GM, Starr LR
    Large Sample Sizes Cannot Compensate for Mismeasured Environments in Gene-by-Environment Research.
    Am J Psychiatry. 2019;176:667-668.

  76. RIGLIN L, Eyre O, Thapar AK, Stringaris A, et al
    Identifying Novel Types of Irritability Using a Developmental Genetic Approach.
    Am J Psychiatry. 2019;176:635-642.
    PubMed     Abstract available

    June 2019
  77. MULLINS N, Bigdeli TB, Borglum AD, Coleman JRI, et al
    GWAS of Suicide Attempt in Psychiatric Disorders and Association With Major Depression Polygenic Risk Scores.
    Am J Psychiatry. 2019 Jun 5:appiajp201918080957.
    PubMed     Abstract available

    From Neurobiology to Novel Medications: A Principled Approach to Translation.
    Am J Psychiatry. 2019;176:425-427.

    A Word to the Wise About Intranasal Esketamine.
    Am J Psychiatry. 2019;176:422-424.

    May 2019
  80. POPOVA V, Daly EJ, Trivedi M, Cooper K, et al
    Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study.
    Am J Psychiatry. 2019 May 21:appiajp201919020172.
    PubMed     Abstract available

    Scientific Issues Relevant to Improving the Diagnosis, Risk Assessment, and Treatment of Major Depression.
    Am J Psychiatry. 2019;176:342-347.
    PubMed     Abstract available

  82. KALIN NH
    Improving the Lives of Patients With Major Depression by Focusing on New Treatment Approaches.
    Am J Psychiatry. 2019;176:329-330.

  83. WEISSMAN MM, Wainberg ML, Olfson M
    Opportunities for Improving Access to Evidence-Based Treatments of Depression.
    Am J Psychiatry. 2019;176:336-337.

  84. PINE DS
    Heterogeneity in Major Depressive Disorder: Lessons From Developmental Research on Irritability.
    Am J Psychiatry. 2019;176:331-332.

  85. HEIFETS BD, Williams NR, Blasey C, Sudheimer K, et al
    Rigorous Translational Models Are Key to Studying Ketamine's Antidepressant Mechanism: Response to Wang and Kaplin.
    Am J Psychiatry. 2019;176:412.

    April 2019
  86. HALLDORSDOTTIR T, Piechaczek C, Soares de Matos AP, Czamara D, et al
    Polygenic Risk: Predicting Depression Outcomes in Clinical and Epidemiological Cohorts of Youths.
    Am J Psychiatry. 2019 Apr 5:appiajp201918091014.
    PubMed     Abstract available

  87. ZISOOK S, Johnson GR, Tal I, Hicks P, et al
    General Predictors and Moderators of Depression Remission: A VAST-D Report.
    Am J Psychiatry. 2019 Apr 5:appiajp201818091079.
    PubMed     Abstract available

    Treatment of Depression Versus Treatment of PTSD.
    Am J Psychiatry. 2019;176:259-261.

  89. RICHARDS M, Grzenda A, Nelson E, Gitlin M, et al
    Psychiatric Comorbidity in Moyamoya Disease and Preliminary Guidelines For Treatment.
    Am J Psychiatry. 2019;176:269-274.

    March 2019
  90. PHILLIPS JL, Norris S, Talbot J, Birmingham M, et al
    Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial.
    Am J Psychiatry. 2019 Mar 29:appiajp201818070834.
    PubMed     Abstract available

  91. JHA MK, Minhajuddin A, South C, Rush AJ, et al
    Irritability and Its Clinical Utility in Major Depressive Disorder: Prediction of Individual-Level Acute-Phase Outcomes Using Early Changes in Irritability and Depression Severity.
    Am J Psychiatry. 2019 Mar 29:appiajp201818030355.
    PubMed     Abstract available

  92. BORDER R, Johnson EC, Evans LM, Smolen A, et al
    No Support for Historical Candidate Gene or Candidate Gene-by-Interaction Hypotheses for Major Depression Across Multiple Large Samples.
    Am J Psychiatry. 2019 Mar 8:appiajp201818070881.
    PubMed     Abstract available

  93. EARLEY W, Victoria Burgess M, Rekeda L, Dickinson R, et al
    Cariprazine Treatment of Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Phase 3 Study.
    Am J Psychiatry. 2019 Mar 8:appiajp201818070824.
    PubMed     Abstract available

    Caution Against Overinterpreting Opiate Receptor Stimulation as Mediating Antidepressant Effects of Ketamine.
    Am J Psychiatry. 2019;176:249.

  95. HEIFETS BD, Williams NR, Blasey C, Sudheimer K, et al
    Interpreting Ketamine's Opioid Receptor Dependent Effect: Response to Sanacora.
    Am J Psychiatry. 2019;176:249-250.

    February 2019
  96. KASTER TS, Downar J, Vila-Rodriguez F, Thorpe KE, et al
    Trajectories of Response to Dorsolateral Prefrontal rTMS in Major Depression: A THREE-D Study.
    Am J Psychiatry. 2019 Feb 15:appiajp201818091096.
    PubMed     Abstract available

  97. DUNLOP BW, LoParo D, Kinkead B, Mletzko-Crowe T, et al
    Benefits of Sequentially Adding Cognitive-Behavioral Therapy or Antidepressant Medication for Adults With Nonremitting Depression.
    Am J Psychiatry. 2019 Feb 15:appiajp201818091075.
    PubMed     Abstract available

  98. SANCHEZ-ROIGE S, Palmer AA, Fontanillas P, Elson SL, et al
    Genome-Wide Association Study Meta-Analysis of the Alcohol Use Disorders Identification Test (AUDIT) in Two Population-Based Cohorts.
    Am J Psychiatry. 2019;176:107-118.
    PubMed     Abstract available

    January 2019
  99. MESSIAS E, Flynn V
    Burnout and Depression: Same Phenomenon or Overlapping Constructs? Response to Bianchi et al.
    Am J Psychiatry. 2019;176:79-80.

  100. BIANCHI R, Schonfeld IS, Laurent E
    The Trouble With Burnout: An Update on Burnout-Depression Overlap.
    Am J Psychiatry. 2019;176:79.

  101. WIDGE AS, Rodriguez CI, Carpenter LL, Kalin NH, et al
    EEG Biomarkers for Treatment Response Prediction in Major Depressive Illness.
    Am J Psychiatry. 2019;176:82.

  102. WIDGE AS, Bilge MT, Montana R, Chang W, et al
    Electroencephalographic Biomarkers for Treatment Response Prediction in Major Depressive Illness: A Meta-Analysis.
    Am J Psychiatry. 2019;176:44-56.
    PubMed     Abstract available

    December 2018
  103. TAYLOR WD, Schultz SK, Panaite V, Steffens DC, et al
    Perspectives on the Management of Vascular Depression.
    Am J Psychiatry. 2018;175:1169-1175.

    November 2018
    Population-Based Estimates of Heritability Shed New Light on Clinical Features of Major Depression.
    Am J Psychiatry. 2018;175:1058-1060.

  105. DING G, Yu J, Vinturache A, Gu H, et al
    Therapeutic Effects of the Traditional "Doing the Month" Practices on Postpartum Depression in China.
    Am J Psychiatry. 2018;175:1071-1072.

  106. SILVERMAN WK, Pettit JW
    Developmental Window of Opportunity: Implications of Parent-Child Psychotherapy for Early Childhood Depression Treatment.
    Am J Psychiatry. 2018;175:1051-1053.

    September 2018
  107. RUSH AJ, Thase ME
    Improving Depression Outcome by Patient-Centered Medical Management.
    Am J Psychiatry. 2018 Sep 17:appiajp201818040398.
    PubMed     Abstract available

  108. BENEDETTI F, Avery DH, Bauer M, Bunney WE, et al
    Evidence for the Efficacy of Bright Light Therapy for Bipolar Depression.
    Am J Psychiatry. 2018;175:905-906.

    August 2018
  109. VULSER H, Paillere Martinot ML, Artiges E, Miranda R, et al
    Early Variations in White Matter Microstructure and Depression Outcome in Adolescents With Subthreshold Depression.
    Am J Psychiatry. 2018 Aug 16:appiajp201817070825.
    PubMed     Abstract available

  110. MCINTOSH AM, Relton C
    Do Depression and Stressful Events Cause Premature Aging?
    Am J Psychiatry. 2018;175:714-715.

  111. WION D
    The Temporal Relationship Between Alzheimer's Disease and Depressive Symptoms: Variable Matters.
    Am J Psychiatry. 2018;175:793.

    July 2018
  112. KENDLER KS, Ohlsson H, Lichtenstein P, Sundquist J, et al
    The Genetic Epidemiology of Treated Major Depression in Sweden.
    Am J Psychiatry. 2018 Jul 19:appiajp201817111251.
    PubMed     Abstract available

  113. COHEN BM, Sommer BR, Vuckovic A
    Antidepressant-Resistant Depression in Patients With Comorbid Subclinical Hypothyroidism or High-Normal TSH Levels.
    Am J Psychiatry. 2018;175:598-604.

  114. ROBERTSON AG, Easter MM, Lin H, Frisman LK, et al
    Medication-Assisted Treatment for Alcohol-Dependent Adults With Serious Mental Illness and Criminal Justice Involvement: Effects on Treatment Utilization and Outcomes.
    Am J Psychiatry. 2018;175:665-673.
    PubMed     Abstract available

    June 2018
  115. KEREN H, O'Callaghan G, Vidal-Ribas P, Buzzell GA, et al
    Reward Processing in Depression: A Conceptual and Meta-Analytic Review Across fMRI and EEG Studies.
    Am J Psychiatry. 2018 Jun 20:appiajp201817101124.
    PubMed     Abstract available

  116. PHAM S, Porta G, Biernesser C, Walker Payne M, et al
    The Burden of Bereavement: Early-Onset Depression and Impairment in Youths Bereaved by Sudden Parental Death in a 7-Year Prospective Study.
    Am J Psychiatry. 2018 Jun 20:appiajp201817070792.
    PubMed     Abstract available

  117. LUBY JL, Barch DM, Whalen D, Tillman R, et al
    A Randomized Controlled Trial of Parent-Child Psychotherapy Targeting Emotion Development for Early Childhood Depression.
    Am J Psychiatry. 2018 Jun 20:appiajp201818030321.
    PubMed     Abstract available

    May 2018
  118. NELSON JC, Bickford D, Delucchi K, Fiedorowicz JG, et al
    Risk of Psychosis in Recurrent Episodes of Psychotic and Nonpsychotic Major Depressive Disorder: A Systematic Review and Meta-Analysis.
    Am J Psychiatry. 2018 May 24:appiajp201817101138.
    PubMed     Abstract available

  119. KAIYA H
    Concerns Regarding the Proposed New Diagnosis of "Modern-Type Depression" in Japan.
    Am J Psychiatry. 2018;175:483.

  120. JUKIC MM, Haslemo T, Molden E, Ingelman-Sundberg M, et al
    Impact of CYP2C19 Genotype on Escitalopram Exposure and Therapeutic Failure: A Retrospective Study Based on 2,087 Patients.
    Am J Psychiatry. 2018;175:463-470.
    PubMed     Abstract available

    April 2018
  121. SCHUCH FB, Vancampfort D, Firth J, Rosenbaum S, et al
    Physical Activity and Incident Depression: A Meta-Analysis of Prospective Cohort Studies.
    Am J Psychiatry. 2018 Apr 25:appiajp201817111194.
    PubMed     Abstract available

  122. CANUSO CM, Singh JB, Fedgchin M, Alphs L, et al
    Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study.
    Am J Psychiatry. 2018 Apr 16:appiajp201817060720.
    PubMed     Abstract available

    Increasing Male Preponderance in Suicide Coinciding With a Reduction by Half in Total Suicides in the Danish Population Should Raise Awareness of Male Depression.
    Am J Psychiatry. 2018;175:381-382.

    March 2018
  124. PETERSON RE, Cai N, Dahl AW, Bigdeli TB, et al
    Molecular Genetic Analysis Subdivided by Adversity Exposure Suggests Etiologic Heterogeneity in Major Depression.
    Am J Psychiatry. 2018 Mar 2:appiajp201717060621.
    PubMed     Abstract available

  125. KALIN NH
    Corticotropin-Releasing Hormone Binding Protein: Stress, Psychopathology, and Antidepressant Treatment Response.
    Am J Psychiatry. 2018;175:204-206.

  126. O'CONNELL CP, Goldstein-Piekarski AN, Nemeroff CB, Schatzberg AF, et al
    Antidepressant Outcomes Predicted by Genetic Variation in Corticotropin-Releasing Hormone Binding Protein.
    Am J Psychiatry. 2018;175:251-261.
    PubMed     Abstract available

  127. WANG Q, Roy B, Turecki G, Shelton RC, et al
    Role of Complex Epigenetic Switching in Tumor Necrosis Factor-alpha Upregulation in the Prefrontal Cortex of Suicide Subjects.
    Am J Psychiatry. 2018;175:262-274.
    PubMed     Abstract available

    February 2018
  128. QUINN DK, Mayer AR, Master CL, Fann JR, et al
    Prolonged Postconcussive Symptoms.
    Am J Psychiatry. 2018;175:103-111.

  129. WILKINSON ST, Ballard ED, Bloch MH, Mathew SJ, et al
    The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis.
    Am J Psychiatry. 2018;175:150-158.
    PubMed     Abstract available

  130. ROBINSON DG, Schooler NR, Correll CU, John M, et al
    Psychopharmacological Treatment in the RAISE-ETP Study: Outcomes of a Manual and Computer Decision Support System Based Intervention.
    Am J Psychiatry. 2018;175:169-179.
    PubMed     Abstract available

    January 2018
  131. SIMON G
    Should Psychiatrists Write the Exercise Prescription for Depression?
    Am J Psychiatry. 2018;175:2-3.

  132. BARKIL-OTEO A, Abdallah W, Mourra S, Jefee-Bahloul H, et al
    Trauma and Resiliency: A Tale of a Syrian Refugee.
    Am J Psychiatry. 2018;175:8-12.

    December 2017
  133. GRUNEBAUM MF, Galfalvy HC, Choo TH, Keilp JG, et al
    Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial.
    Am J Psychiatry. 2017 Dec 5:appiajp201717060647.
    PubMed     Abstract available

  134. RUTHERFORD BR, Brewster K, Golub JS, Kim AH, et al
    Sensation and Psychiatry: Linking Age-Related Hearing Loss to Late-Life Depression and Cognitive Decline.
    Am J Psychiatry. 2017 Dec 5:appiajp201717040423.
    PubMed     Abstract available

  135. DAVIES RD, Kessel B
    Gender Minority Stress, Depression, and Anxiety in a Transgender High School Student.
    Am J Psychiatry. 2017;174:1151-1152.

    November 2017
  136. BARTELS C, Wagner M, Wolfsgruber S, Ehrenreich H, et al
    Impact of SSRI Therapy on Risk of Conversion From Mild Cognitive Impairment to Alzheimer's Dementia in Individuals With Previous Depression.
    Am J Psychiatry. 2017 Nov 28:appiajp201717040404.
    PubMed     Abstract available

  137. KATO TA, Kanba S
    Modern-Type Depression as an "Adjustment" Disorder in Japan: The Intersection of Collectivistic Society Encountering an Individualistic Performance-Based System.
    Am J Psychiatry. 2017;174:1051-1053.

  138. PAN PM, Sato JR, Salum GA, Rohde LA, et al
    Ventral Striatum Functional Connectivity as a Predictor of Adolescent Depressive Disorder in a Longitudinal Community-Based Sample.
    Am J Psychiatry. 2017;174:1112-1119.
    PubMed     Abstract available

  139. KOTOV R, Fochtmann L, Li K, Tanenberg-Karant M, et al
    Declining Clinical Course of Psychotic Disorders Over the Two Decades Following First Hospitalization: Evidence From the Suffolk County Mental Health Project.
    Am J Psychiatry. 2017;174:1064-1074.
    PubMed     Abstract available

  140. VELTHORST E, Fett AJ, Reichenberg A, Perlman G, et al
    The 20-Year Longitudinal Trajectories of Social Functioning in Individuals With Psychotic Disorders.
    Am J Psychiatry. 2017;174:1075-1085.
    PubMed     Abstract available

    October 2017
  141. HARVEY SB, Overland S, Hatch SL, Wessely S, et al
    Exercise and the Prevention of Depression: Results of the HUNT Cohort Study.
    Am J Psychiatry. 2017 Oct 3:appiajp201716111223.
    PubMed     Abstract available

  142. THASE ME, Wright JH, Eells TD, Barrett MS, et al
    Improving the Efficiency of Psychotherapy for Depression: Computer-Assisted Versus Standard CBT.
    Am J Psychiatry. 2017 Oct 3:appiajp201717010089.
    PubMed     Abstract available

  143. SIT DK, McGowan J, Wiltrout C, Diler RS, et al
    Adjunctive Bright Light Therapy for Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Trial.
    Am J Psychiatry. 2017 Oct 3:appiajp201716101200.
    PubMed     Abstract available

  144. STEINERT C, Munder T, Rabung S, Hoyer J, et al
    Psychodynamic Therapy: As Efficacious as Other Empirically Supported Treatments? A Meta-Analysis Testing Equivalence of Outcomes.
    Am J Psychiatry. 2017;174:943-953.
    PubMed     Abstract available

  145. SCHMIDT PJ, Martinez PE, Nieman LK, Koziol DE, et al
    Premenstrual Dysphoric Disorder Symptoms Following Ovarian Suppression: Triggered by Change in Ovarian Steroid Levels But Not Continuous Stable Levels.
    Am J Psychiatry. 2017;174:980-989.
    PubMed     Abstract available

  146. DOMINGUE BW, Liu H, Okbay A, Belsky DW, et al
    Genetic Heterogeneity in Depressive Symptoms Following the Death of a Spouse: Polygenic Score Analysis of the U.S. Health and Retirement Study.
    Am J Psychiatry. 2017;174:963-970.
    PubMed     Abstract available

    September 2017
  147. PADALA PR, Padala KP, Lensing SY, Ramirez D, et al
    Methylphenidate for Apathy in Community-Dwelling Older Veterans With Mild Alzheimer's Disease: A Double-Blind, Randomized, Placebo-Controlled Trial.
    Am J Psychiatry. 2017 Sep 15:appiajp201717030316.
    PubMed     Abstract available

  148. BLUM LD
    An Unexpected Sight in the Rearview Mirror.
    Am J Psychiatry. 2017;174:832.

    August 2017
    Amygdala-Guided Neurofeedback for Major Depression.
    Am J Psychiatry. 2017;174:717-718.

  150. YOUNG KD, Siegle GJ, Zotev V, Phillips R, et al
    Randomized Clinical Trial of Real-Time fMRI Amygdala Neurofeedback for Major Depressive Disorder: Effects on Symptoms and Autobiographical Memory Recall.
    Am J Psychiatry. 2017;174:748-755.
    PubMed     Abstract available

    July 2017
  151. LI L, Li Y, Zheng Q
    High Placebo Response Rates Hamper the Discovery of Antidepressants for Depression in Children and Adolescents.
    Am J Psychiatry. 2017;174:696-697.

  152. PHILIP NS, Nelson BG, Frohlich F, Lim KO, et al
    Low-Intensity Transcranial Current Stimulation in Psychiatry.
    Am J Psychiatry. 2017;174:628-639.
    PubMed     Abstract available

  153. SHARMA A, Wolf DH, Ciric R, Kable JW, et al
    Common Dimensional Reward Deficits Across Mood and Psychotic Disorders: A Connectome-Wide Association Study.
    Am J Psychiatry. 2017;174:657-666.
    PubMed     Abstract available

  154. GARCINI LM, Pena JM, Galvan T, Fagundes CP, et al
    DREAMers Living in the United States: A Contextual Perspective and Clinical Implications.
    Am J Psychiatry. 2017;174:623-625.

  155. PARKS KA, Parks CG, Onwuameze OE, Shrestha S, et al
    Psychiatric Complications of Primary Hyperparathyroidism and Mild Hypercalcemia.
    Am J Psychiatry. 2017;174:620-622.

  156. WILKINSON ST, Toprak M, Turner MS, Levine SP, et al
    A Survey of the Clinical, Off-Label Use of Ketamine as a Treatment for Psychiatric Disorders.
    Am J Psychiatry. 2017;174:695-696.

    June 2017
  157. MING Q, Zhong X, Zhang X, Pu W, et al
    State-Independent and Dependent Neural Responses to Psychosocial Stress in Current and Remitted Depression.
    Am J Psychiatry. 2017 Jun 16:appiajp201716080974.
    PubMed     Abstract available

  158. DAVEY CG, Breakspear M, Pujol J, Harrison BJ, et al
    A Brain Model of Disturbed Self-Appraisal in Depression.
    Am J Psychiatry. 2017 Jun 9:appiajp201716080883.
    PubMed     Abstract available

    Getting Personalized: Brain Scan Biomarkers for Guiding Depression Interventions.
    Am J Psychiatry. 2017;174:503-505.

  160. DUNLOP BW, Rajendra JK, Craighead WE, Kelley ME, et al
    Functional Connectivity of the Subcallosal Cingulate Cortex And Differential Outcomes to Treatment With Cognitive-Behavioral Therapy or Antidepressant Medication for Major Depressive Disorder.
    Am J Psychiatry. 2017;174:533-545.
    PubMed     Abstract available

  161. RUSH AJ
    Engaging Depressed Patients: An Essential Step in Optimizing Care.
    Am J Psychiatry. 2017;174:506-507.

    May 2017
  162. LEUCHT S, Leucht C, Huhn M, Chaimani A, et al
    Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors.
    Am J Psychiatry. 2017 May 25:appiajp201716121358.
    PubMed     Abstract available

  163. MARDER SR, Gitlin MJ
    A Cruel Irony for Clinicians Who Treat Depression.
    Am J Psychiatry. 2017;174:409-410.

  164. SINGH AB, Bousman CA
    Antidepressant Pharmacogenetics.
    Am J Psychiatry. 2017;174:417-418.

    April 2017
  165. KELLNER CH, Knapp RG, Petrides G, McCall WV, et al
    A Step Toward Optimizing Treatment Schedules for Continuation ECT: Response to Rasmussen.
    Am J Psychiatry. 2017;174:397-398.

    Searching for Optimal Treatment Schedules for Longitudinal ECT.
    Am J Psychiatry. 2017;174:397.

    March 2017
  167. AARONSON ST, Sears P, Ruvuna F, Bunker M, et al
    A 5-Year Observational Study of Patients With Treatment-Resistant Depression Treated With Vagus Nerve Stimulation or Treatment as Usual: Comparison of Response, Remission, and Suicidality.
    Am J Psychiatry. 2017 Mar 31:appiajp201716010034.
    PubMed     Abstract available

  168. DUNLOP BW, Kelley ME, Aponte-Rivera V, Mletzko-Crowe T, et al
    Effects of Patient Preferences on Outcomes in the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) Study.
    Am J Psychiatry. 2017 Mar 24:appiajp201616050517.
    PubMed     Abstract available

  169. WALKUP JT
    Antidepressant Efficacy for Depression in Children and Adolescents: Industry- and NIMH-Funded Studies.
    Am J Psychiatry. 2017 Mar 3:appiajp201716091059.
    PubMed     Abstract available

  170. TAYLOR WD
    Lack of a Role for Alzheimer's Disease Pathology in Late-Life Depression, or Just No Relationship With Amyloid?
    Am J Psychiatry. 2017;174:197-198.

  171. BRYANT RA, Gallagher HC, Gibbs L, Pattison P, et al
    Mental Health and Social Networks After Disaster.
    Am J Psychiatry. 2017;174:277-285.
    PubMed     Abstract available

  172. PATERSON C, Wang Y, Hyde TM, Weinberger DR, et al
    Temporal, Diagnostic, and Tissue-Specific Regulation of NRG3 Isoform Expression in Human Brain Development and Affective Disorders.
    Am J Psychiatry. 2017;174:256-265.
    PubMed     Abstract available

  173. HOFFMAN MC, Wisner KL
    Psychiatry and Obstetrics: An Imperative for Collaboration.
    Am J Psychiatry. 2017;174:205-207.

    February 2017
  174. RUTHERFORD BR, Wall MM, Brown PJ, Choo TH, et al
    Patient Expectancy as a Mediator of Placebo Effects in Antidepressant Clinical Trials.
    Am J Psychiatry. 2017;174:135-142.
    PubMed     Abstract available

    January 2017
  175. ALTSHULER LL, Sugar CA, McElroy SL, Calimlim B, et al
    Switch Rates During Acute Treatment for Bipolar II Depression With Lithium, Sertraline, or the Two Combined: A Randomized Double-Blind Comparison.
    Am J Psychiatry. 2017 Jan 31:appiajp201615040558.
    PubMed     Abstract available

  176. NELSON JC, Spyker DA
    Morbidity and Mortality Associated With Medications Used in the Treatment of Depression: An Analysis of Cases Reported to U.S. Poison Control Centers, 2000-2014.
    Am J Psychiatry. 2017 Jan 31:appiajp201616050523.
    PubMed     Abstract available

  177. MARSHE VS, Maciukiewicz M, Rej S, Tiwari AK, et al
    Norepinephrine Transporter Gene Variants and Remission From Depression With Venlafaxine Treatment in Older Adults.
    Am J Psychiatry. 2017 Jan 10:appiajp201616050617.
    PubMed     Abstract available

  178. MATHEW SJ, Lijffijt M
    Neurometabolic Abnormalities in Treatment-Resistant Depression.
    Am J Psychiatry. 2017;174:3-5.

  179. EISENLOHR-MOUL TA, Girdler SS, Schmalenberger KM, Dawson DN, et al
    Toward the Reliable Diagnosis of DSM-5 Premenstrual Dysphoric Disorder: The Carolina Premenstrual Assessment Scoring System (C-PASS).
    Am J Psychiatry. 2017;174:51-59.
    PubMed     Abstract available

  180. EPPERSON CN, Hantsoo LV
    Making Strides to Simplify Diagnosis of Premenstrual Dysphoric Disorder.
    Am J Psychiatry. 2017;174:6-7.

  181. DAVIS RA, Epstein CH, Klepitskaya O, Sharp CS, et al
    Disambiguating the Psychiatric Sequelae of Parkinson's Disease, Deep Brain Stimulation, and Life Events: Case Report and Literature Review.
    Am J Psychiatry. 2017;174:11-15.

    December 2016
  182. JHA MK, Minhajuddin A, Greer TL, Carmody T, et al
    Early Improvement in Work Productivity Predicts Future Clinical Course in Depressed Outpatients: Findings From the CO-MED Trial.
    Am J Psychiatry. 2016;173:1196-1204.
    PubMed     Abstract available

    November 2016
  183. JUDD LL, Schettler PJ, Rush AJ
    A Brief Clinical Tool to Estimate Individual Patients' Risk of Depressive Relapse Following Remission: Proof of Concept.
    Am J Psychiatry. 2016;173:1140-1146.
    PubMed     Abstract available

    October 2016
  184. ADMON R, Kaiser RH, Dillon DG, Beltzer M, et al
    Dopaminergic Enhancement of Striatal Response to Reward in Major Depression.
    Am J Psychiatry. 2016 Oct 24:appiajp201616010111.
    PubMed     Abstract available

  185. WEISSMAN MM, Wickramaratne P, Gameroff MJ, Warner V, et al
    Offspring of Depressed Parents: 30 Years Later.
    Am J Psychiatry. 2016;173:1024-1032.
    PubMed     Abstract available

    September 2016
  186. MORIGUCHI S, Yamada M, Takano H, Nagashima T, et al
    Norepinephrine Transporter in Major Depressive Disorder: A PET Study.
    Am J Psychiatry. 2016 Sep 15:appiajp201615101334.
    PubMed     Abstract available

  187. BERGINK V, Rasgon N, Wisner KL
    Postpartum Psychosis: Madness, Mania, and Melancholia in Motherhood.
    Am J Psychiatry. 2016 Sep 9:appiajp201616040454.
    PubMed     Abstract available

  188. PHILLIPS KA, Keshaviah A, Dougherty DD, Stout RL, et al
    Pharmacotherapy Relapse Prevention in Body Dysmorphic Disorder: A Double-Blind, Placebo-Controlled Trial.
    Am J Psychiatry. 2016;173:887-95.
    PubMed     Abstract available

    July 2016
  189. CUIJPERS P, Donker T, Weissman MM, Ravitz P, et al
    Interpersonal Psychotherapy for Mental Health Problems: A Comprehensive Meta-Analysis.
    Am J Psychiatry. 2016;173:680-7.
    PubMed     Abstract available

    June 2016
  190. HELFER B, Samara MT, Huhn M, Klupp E, et al
    Efficacy and Safety of Antidepressants Added to Antipsychotics for Schizophrenia: A Systematic Review and Meta-Analysis.
    Am J Psychiatry. 2016 Jun 10:appiajp201615081035.
    PubMed     Abstract available

  191. VERHOEVEN JE, van Oppen P, Revesz D, Wolkowitz OM, et al
    Depressive and Anxiety Disorders Showing Robust, but Non-Dynamic, 6-Year Longitudinal Association With Short Leukocyte Telomere Length.
    Am J Psychiatry. 2016;173:617-24.
    PubMed     Abstract available

    March 2016
  192. MONK C, Feng T, Lee S, Krupska I, et al
    Distress During Pregnancy: Epigenetic Regulation of Placenta Glucocorticoid-Related Genes and Fetal Neurobehavior.
    Am J Psychiatry. 2016 Mar 25:appiajp201515091171.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Depression is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.